These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 1271887

  • 1. Intralesional immunotherapy of melanoma with BCG.
    Rosenberg SA, Rapp HJ.
    Med Clin North Am; 1976 May; 60(3):419-30. PubMed ID: 1271887
    [Abstract] [Full Text] [Related]

  • 2. Intralesional treatment of recurrent metastatic cutaneous malignant melanoma: a randomized prospective study of intralesional Bacillus Calmette-Guerin versus intralesional dinitrochlorobenzene.
    Cohen MH, Jessup JM, Felix EL, Weese JL, Herberman RB.
    Cancer; 1978 Jun; 41(6):2456-63. PubMed ID: 657108
    [Abstract] [Full Text] [Related]

  • 3. Immunotherapy of melanoma with intralesional BCG.
    Bornstein RS, Mastrangelo MJ, Sulit H, Chee D, Yarbro JW, Prehn LM, Prehn RT.
    Natl Cancer Inst Monogr; 1973 Dec; 39():213-20. PubMed ID: 4595320
    [No Abstract] [Full Text] [Related]

  • 4. The immunologic and histopathologic changes of BCG-mediated tumor regression in patients with malignant melanoma.
    Lieberman R, Wybran J, Epstein W.
    Cancer; 1975 Mar; 35(3):756-77. PubMed ID: 234295
    [Abstract] [Full Text] [Related]

  • 5. Re-inventing intratumoral immunotherapy for melanoma.
    Triozzi PL, Tuthill RJ, Borden E.
    Immunotherapy; 2011 May; 3(5):653-71. PubMed ID: 21554094
    [Abstract] [Full Text] [Related]

  • 6. Fatal disseminated bacillus Calmette-Guerin infection and arrested growth of cutaneous malignant melanoma following intralesional immunotherapy.
    de la Monte SM, Hutchins GM.
    Am J Dermatopathol; 1986 Aug; 8(4):331-5. PubMed ID: 3532854
    [Abstract] [Full Text] [Related]

  • 7. Intralesional BCG, intravenous immune lymphocytes, and immunization with neuraminidase-treated tumor cells to manage melanoma; A clinical assessment.
    Seigler HF, Shingleton WW, Pickrell KL.
    Plast Reconstr Surg; 1975 Mar; 55(3):294-8. PubMed ID: 1118487
    [Abstract] [Full Text] [Related]

  • 8. Immunology and cutaneous malignant melanoma.
    Sober AJ.
    Int J Dermatol; 1976 Mar; 15(1):1-18. PubMed ID: 1107238
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Regression of pulmonary metastatic disease associated with intralesional BCG therapy of intracutaneous melanoma metastases.
    Mastrangelo MJ, Bellet RE, Berkelhammer J, Clark WH.
    Cancer; 1975 Oct; 36(4):1305-8. PubMed ID: 1175129
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. BCG immunotherapy of malignant melanoma: summary of a seven-year experience.
    Morton DL, Eilber FR, Holmes EC, Hunt JS, Ketcham AS, Silverstein MJ, Sparks FC.
    Ann Surg; 1974 Oct; 180(4):635-43. PubMed ID: 4412271
    [Abstract] [Full Text] [Related]

  • 17. [Immunotherapy with BCG as coadjuvant in the management of malignant melanomas].
    Céspedes de Gómez MM, Aguilar Velázquez G, Valles de Cortés Y.
    Alergia; 1980 Apr; 27(2):69-86. PubMed ID: 7416444
    [No Abstract] [Full Text] [Related]

  • 18. Results of adjuvant BCG immunotherapy in malignant melanoma.
    Wätzig V, Knopf B.
    Arch Geschwulstforsch; 1981 Apr; 51(6):493-6. PubMed ID: 7332442
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Complete remission of metastatic malignant melanoma following immunotherapy with Bacillus Calmette-Guerin (BCG): report of a case.
    Coates AS, Peters M.
    Aust N Z J Surg; 1977 Jun; 47(3):362-5. PubMed ID: 269705
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.